Skip to main content
Log in

Urinary mulberry cells and mulberry bodies are useful tool to detect late-onset Fabry disease

  • Case report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Fabry disease is an X-linked lysosomal storage disorder caused by a lack of α-galactosidase A activity, which leads to the accumulation of globotriaosylceramide in various organs. A complete lack of α-galactosidase A activity in a hemizygous male is the classical phenotype, and some hemizygous males show primarily cardiac and/or renal symptoms that appear in adulthood; this is called the variant type or the late-onset type. The kidney and heart are the major target organs, with damage to these organs related to mortality. Thus, in Fabry patients, early detection and early treatment are critical to longevity. Here, we present a 55-year-old Japanese male patient who was diagnosed with late-onset Fabry nephropathy with cardiomyopathy but with no abnormal urinary findings except for urinary mulberry cells and mulberry bodies. In spite of the absence of abnormal urinary findings, the light microscopic and electron microscopic pathological findings showed extensive deposition of globotriaosylceramide to podocytes. In this paper, we propose that the presence of mulberry cells and mulberry bodies can be used for the earlier detection of Fabry nephropathy, especially the late-onset type.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kint JA. Fabry’s disease: alpha-galactosidase deficiency. Science. 1970;167:1268–9.

    Article  CAS  Google Scholar 

  2. Tondel C, Bostad L, Larsen KK, et al. Agalsidase benefits renal histology in young patients with Fabry disease. J Am Soc Nephrol. 2013;24:137–8.

    Article  CAS  Google Scholar 

  3. Pisani A, Visciano B, Imbriaco M, et al. The kidney in Fabry’s disease. Clin Genet. 2014;86:301–9.

    Article  CAS  Google Scholar 

  4. Terryn W, Cochat P, Froissart R, et al. Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice. Nephrol Dial Transplant. 2013;28:505–17.

    Article  Google Scholar 

  5. Ortiz A, Oliveira JP, Wanner C, Brenner BM, Waldek S, Warnock DG. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults. Nat Clin Pract Nephrol. 2008;4:327–36.

    Article  Google Scholar 

  6. Nakao S, Takenaka T, Maeda M, et al. An atypical variant of Fabry’s disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288–93.

    Article  CAS  Google Scholar 

  7. Nakao S, Kodama C, Takenaka T, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype. Kidney Int. 2003;64:801–7.

    Article  Google Scholar 

  8. Tondel C, Kanai T, Larsen KK, et al. Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria. Nephron. 2015;129:16–21.

    Article  CAS  Google Scholar 

  9. Eng CE, Fletcher J, Wilcox WR, et al. Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis. 2007;30:182.

    Article  Google Scholar 

  10. Trimarchi H, Canzonieri R, Muryan A, et al. Copious podocyturia without proteinuria and with normal renal function in a young adult with Fabry disease. Case Rep Nephrol. 2015;257628.

  11. Becher GJ, Nicholls K. Lipiduria-with special relevance to Fabry disease. Clin Chem Lab Med. 2015;53:s1465–70.

    Google Scholar 

  12. Nakamichi T, Miyazaki M, Nakayama K, et al. Fabry’s disease discovered with chance urinary mulberry cells: a case report. CEN Case Rep. 2013;2:49–52.

    Article  Google Scholar 

  13. Honda T, Komatsu E, Furuse S, Mise N. Fabry disease diagnosed based on the detection of urinary mulberry bodies. Int Med. 2016;55:2903.

    Article  Google Scholar 

  14. Shimohata H, Ogawa Y, Maruyama H, Hirayama K, Kobayashi M. A case of renal variant of Fabry disease diagnosed by the presence of urinary mulberry cells. Int Med. 2016;55:3475–8.

    Article  Google Scholar 

  15. Najafian B, Svarstad E, Bostad L, et al. Progressive podocyte injury and globotriaosylceramide (Gb-3) accumulation in young patients with Fabry disease. Kidney Int. 2010;79:663–70.

    Article  Google Scholar 

  16. Tondel C, Bostad L, Hirth A, Svarstad E. Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. Am J Kidney Dis. 2008;51:767–76.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Homare Shimohata.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

Human and animal rights

This article does not contain any studies with human participants performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shimohata, H., Maruyama, H., Miyamoto, Y. et al. Urinary mulberry cells and mulberry bodies are useful tool to detect late-onset Fabry disease. CEN Case Rep 6, 148–151 (2017). https://doi.org/10.1007/s13730-017-0262-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-017-0262-5

Keywords

Navigation